Cargando…
Apatinib + CPT-11 + S-1 for treatment of refractory brain metastases in patient with triple-negative breast cancer: Case report and literature review
RATIONALE: Brain metastasis (BM) is a rising challenge in forward-looking oncology, as its treatment choices are very limited, especially, after the failure of local treatment schemes. PATIENT CONCERNS: We report on a 39-year-old Chinese woman who was diagnosed with stage IV triple-negative breast c...
Autores principales: | Hu, Ting, Liu, Cuiwei, Li, Qiuhui, Xiong, Jie, Ma, Yuxi, Wu, Gang, Zhao, Yanxia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908627/ https://www.ncbi.nlm.nih.gov/pubmed/29642175 http://dx.doi.org/10.1097/MD.0000000000010349 |
Ejemplares similares
-
Rare metastasis to paranasal sinuses from triple-negative breast cancer: A case report and literature review
por: Xiong, Jie, et al.
Publicado: (2017) -
Hypoxia-mediated activation of hypoxia-inducible factor-1α in triple-negative breast cancer: A review
por: Liu, Lihui, et al.
Publicado: (2023) -
Prognostic value of IMP3 immunohistochemical expression in triple negative breast cancer
por: Sjekloča, Nikoleta, et al.
Publicado: (2020) -
MicroRNAs in the prognosis of triple-negative breast cancer: A systematic review and meta-analysis
por: Lü, Lingshuang, et al.
Publicado: (2017) -
Features of triple-negative breast cancer: Analysis of 38,813 cases from the national cancer database
por: Plasilova, Magdalena L., et al.
Publicado: (2016)